cyqualon has been researched along with bisdemethoxycurcumin in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Artico, M; Costi, R; De Montis, A; Di Santo, R; Greco, G; La Colla, P; Marongiu, ME; Massa, S; Novellino, E; Tramontano, E | 1 |
Assefa, H; Buolamwini, JK | 1 |
Bahety, P; Boon, CP; Ee, PL; Lee, CY; Leow, PC; Tan, KL; Yang, T | 1 |
Deck, LM; Hunsaker, LA; Royer, RE; Vander Jagt, DL; Vander Jagt, TA; Whalen, LJ | 1 |
4 other study(ies) available for cyqualon and bisdemethoxycurcumin
Article | Year |
---|---|
Geometrically and conformationally restrained cinnamoyl compounds as inhibitors of HIV-1 integrase: synthesis, biological evaluation, and molecular modeling.
Topics: Anti-HIV Agents; Antineoplastic Agents; Cell Division; Cinnamates; Crystallography, X-Ray; HIV Integrase Inhibitors; HIV-1; Humans; Models, Molecular; Structure-Activity Relationship; Tumor Cells, Cultured; Virus Replication | 1998 |
CoMFA and CoMSIA 3D QSAR and docking studies on conformationally-restrained cinnamoyl HIV-1 integrase inhibitors: exploration of a binding mode at the active site.
Topics: Binding Sites; Cinnamates; HIV Integrase Inhibitors; HIV-1; Models, Molecular; Protein Binding; Quantitative Structure-Activity Relationship | 2002 |
Functionalized curcumin analogs as potent modulators of the Wnt/β-catenin signaling pathway.
Topics: Antineoplastic Agents; beta Catenin; Bone Neoplasms; Cell Line, Tumor; Curcumin; HEK293 Cells; Humans; Neoplasm Invasiveness; Osteosarcoma; Wnt Signaling Pathway | 2014 |
Activation of anti-oxidant Nrf2 signaling by enone analogues of curcumin.
Topics: Curcumin; Dose-Response Relationship, Drug; Hep G2 Cells; Humans; Ketones; Molecular Structure; NF-E2-Related Factor 2; Oxidants; Signal Transduction; Structure-Activity Relationship | 2018 |